ZOLMITRIPTAN TABLET
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP22F1468 to DMS Pharmaceutical Group Inc. for the procurement of Zolmitriptan tablets under the broader delivery order SPE2DX15D9383. This federal procurement action was managed by the Department of Defense through the DLA Troop Support Medical Supply Chain FSB, with the overarching delivery order carrying a total award amount of 4,999,999.00 dollars. Despite the initial award, contract modification P00001 issued on August 25, 2026, resulted in a total cancellation of the order at no cost or liability to either the government or the contractor. This cancellation, which reduced the value of CLIN 0001 to zero, was implemented because the associated ships were being decommissioned and both parties agreed to non-performance.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
